XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders Equity (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Apr. 12, 2024
May 17, 2024
Jan. 17, 2024
Jun. 30, 2024
Warrants exercise price     $ 2.50  
Replacement Warrants, outstanding     333,884  
Salary for Equity Incentive Options [Member]        
Issued stock options, value   $ 948,200    
Exercise price   $ 2.50    
Options vesting period   over twelve months    
Issued stock options, shares   628,960    
Equity Cancel and Replacement Options [Member] | April 1, 2024 [Member]        
Exercise price       $ 2.50
Options vesting period       over the three year
Recognize stock compensation expense       $ 613,400
Securities Purchase Agreement        
Securities Purchase Agreement, Description     the Company sold an aggregate of 358,388 Units, comprising 358,388 shares of the Company’s common stock, par value $.05 per share (“Common Stock”) and warrants (“Warrants”) to purchase 358,388 shares of Common Stock for a total consideration of $716,776. The Company recognized $98,700 of issuance cost, which includes $71,100 attributable to legal and placement agent fees and $27,600 attributable to the fair value of warrants, issued to the placement agent, to purchase up to 17,919 shares of Common Stock at an exercise price of $2.00 per share on substantially the same terms as the Warrants issued to the purchasers of Units (“Investors”).  
Board of Director Stock Options [Member]        
Issued stock options, value $ 34,500      
Exercise price $ 1.75      
Options vesting period over three years      
Issued stock options, shares 25,000